Neurobiology of Aging
Volume 30, Issue 9 , Pages 1350-1360 , September 2009

APOE genotype-specific differences in the innate immune response

  • Michael P. Vitek
    • ,
  • Candice M. Brown

      Affiliations

    • Present address: Department of Physiology and Biophysics, School of Medicine, University of Washington, 1959 NE Pacific Street, Box 357290, Seattle, WA 98195, USA.
    • ,
  • Carol A. Colton

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +1 919 668 2758; fax: +1 919 684 6514.

Received 19 September 2007 ,Revised 31 October 2007 ,Accepted 10 November 2007.

References 

  1. Adams D, Hamilton T. The cell biology of macrophage activation. Annu. Rev. Immunol. 1984;2:283–318
  2. Avila E, Holdsworth G, Sasaki N, Jackson R, Harmony J. Apolipoprotein E suppresses phytohemagglutinin-activated phospholipid turnover in peripheral blood mononuclear cells. J. Biol. Chem. 1982;257:5900–5909
  3. Barger S, Harmon A. Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E. Nature. 1997;388:878–881
  4. Brown C, Wright E, Colton C, Sullivan P, Laskowitz D, Vitek M. Apolipoprotein E isoform mediated regulation of nitric oxide release. Free Radic. Biol. Med. 2002;32:1071–1075
  5. Brown C, Xu Q, Okhubo N, Vitek M, Colton CA. Androgen-mediated immune function is altered by the apolipoprotein E gene. Endocrinology. 2007;148:3390
  6. Brown, C., Choi, E., Xu, Q., Vitek, M., Colton, C.A., 2007. The APOE4 genotype alters the response of microglia and macrophages to 17beta-estradiol. Neurobiol. Aging, June 4 (Epub ahead of print)
  7. Chapman J, Vinokurov S, Achiron A, Karussis D, Mitosek-Sewczyk K, Birnbaum M, et al. APOE genotype is a major predictor of long term progression of disability in MS. Neurology. 2001;56:312–316
  8. Colton C, Brown C, Czapiga M, Vitek M. Apolipoprotein-E allele specific regulation of nitric oxide production. N.Y. Acad. Sci. 2002;962:212–225
  9. Colton CA, Brown C, Cook D, Needham L, Xu Q, Czapiga M, et al. APOE and the regulation of microglial nitric oxide production: a link between genetic risk and oxidative stress. Neurobiol. Aging. 2002;23:777–785
  10. Colton C, Brown C, Vitek M. Sex steroids APOE genotype and the innate immune system. Neurobiol. Aging. 2005;26:363–372
  11. Coon KD, Myers AJ, Craig DW, Webster JA, Pearson JV, Lince DH, et al. A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease. J. Clin. Psychiatry. 2007;68:613–618
  12. Corder E, Robertson K, Lannfelt L, Bogdanovic N, Eggertsen G, Wilkins J, et al. HIV-infected subjects with the E4 allele for APOE have excess dementia and peripheral neuropathy. Nat. Med. 1998;4:1182–1184
  13. Czapiga M, Colton CA. Microglial function in human APOE3 and APOE4 transgenic mice: altered arginine transport. J. Neuroimmunol. 2002;4673:1–8
  14. deBont N, Netea M, Demacker P, Verschureren I, Kullberg B, van Dijk K, et al. Apolipoprotein E knock-out mice are highly susceptible to endotoxemia and Klebsiella pneumoniae infection. J. Lipid Res. 1999;40:680–685
  15. Finch CE, Morgan T. Systemic inflammation, infection, ApoE alleles, and Alzheimer disease: a position paper. Curr. Alzheimer Res. 2007;4:185–189
  16. Garvey E, Oplinger J, Furfine E, Kiff R, Laszlo F, Whittle B, et al. 1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo. J. Biol. Chem. 1997;272:4959–4963
  17. Gordon S. Alternative activation of macrophages. Nat. Rev. Immunol. 2003;3:23–35
  18. Grocott H, Newman M, El-Moalem H, Bainbridge D, Butler A, Laskowitz D. Apolipoprotein E genotype differentially influences the pro-inflammatory and anti-inflammatory response to cardiopulmonary bypass. J. Thorac. Cardiovasc. Surg. 2001;122:622–623
  19. Guo L, LaDu M, Van Eldik L. A dual role for apolipoprotein E in neuroinflammation: anti- and pro-inflammatory activity. J. Mol. Neurosci. 2004;23:205–212
  20. Hui D, Harmony J, Inneraity T, Mahley R. Immunoregulatory plasma lipoproteins role of apoprotein E and apoprotein B. J. Biol. Chem. 1980;255:11775–11781
  21. Jofre Monseny L, Lobada A, Wagner AE, Huebbe P, Boesch-Saadatmandi C, Kozkowicz A, et al. Effects of apoE genotype on macrophage inflammation and heme oxygenase-1 expression. Biochem. Biophys. Res. Commun. 2007;357:319–324
  22. Jordan B, Relkin N, Ravdin L, Jacobs A, Bennett A, Gandy S. Apolipoprotein E epsilon4 associated with chronic traumatic brain injury in boxing. J. Am. Med. Soc. 1997;278:2143–2145
  23. Kakuda D, Sweet MJ, MacLeod C, Hume D, Markovich D. CAT2-mediated l-arginine transport and nitric oxide production in activated macrophages. Biochem. J. 1999;340:549–553
  24. Kutner K, Erlanger D, Tsai J, Jordon B, Relkin N. Lower cognitive performance of older football players possessing apolipoprotein E epsilon4. Neurosurgery. 2000;47:651–657
  25. Laskowitz D, Lee D, Schmechel D, Staats H. Altered immune responses in apolipoprotein E-deficient mice. J. Lipid Res. 2000;41:613–620
  26. Laskowitz D, Thekdi A, Han S, Myers J, Pizzo S, Bennett E. Down regulation of microglial activation by apolipoprotein E and apoE mimetic peptides. Exp. Neurol. 2001;167:74–85
  27. Laskowitz D, McKenna S, Song P, Wang H, Durham L, Yeung N, et al. COG1410, a novel apolipoprotein E-based peptide, improves functional recovery in a murine model of traumatic brain injury. J. Neurotrauma. 2007;24:1093–1107
  28. Lehnardt S, Massillon L, Follett P, Jensen F, Ratan R, Rosenberg P, et al. Activation of innate immunity in the CNS triggers neurodegeneration through a Toll like receptor 4 dependent pathway. Proc. Natl. Acad. Sci. 2003;10:8514–8519
  29. Lerma J, Herranz AS, Herreras O, Abraira V, Martin Del Rio R. In vivo determination of extracellular concentration of amino acids in the rat hippocampus. A method based on brain dialysis and computerized analysis. Brain Res. 1986;384:145–155
  30. Licastro F, Porcellini E, Caruso D, Lio D, Corder E. Genetic risk profiles for Alzheimer's disease: integration of APOE genotype and variants that up-regulate inflammation. Neurobiol. Aging. 2007;28:1637–1643
  31. Livak KJ, Schmittgen T. Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods. 2001;25:402–408
  32. Lynch J, Morgan D, Mance J, Matthew W, Laskowitz D. Apolipoprotein E modulates glial activation and the endogenous central nervous system inflammatory response. J. Neuroimmunol. 2001;114:107–113
  33. Macy M, Okano Y, Cardin A, Avila E, Harmony J. Suppression of lymphocyte activation by plasma lipoproteins. Cancer Res. 1983;43(Suppl. 5):2496s–2502s
  34. Maezawa I, Maeda N, Montine T, Montine K. Apolipoprotein E-specific innate immune response in astrocytes from targeted replacement mice. J. Neuroinflamm. 2006;3:10
  35. Maezawa I, Nivison M, Montine K, Maeda N, Montine T. Neurotoxicity from innate immune response is greatest with targeted replacement of E4 allele of apolipoprotein E gene and is mediated by microglial p38MAPK. FASEB J. 2006;20:797–799
  36. Mahley R, Weisberger K, Huang Y. Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 2006;103:5641–5643
  37. Nathoo N, Chetty R, van Dellen J, Barnett G. Genetic vulnerability following traumatic brain injury: the role of apolipoprotein E. Mol. Pathol. 2003;56:132–136
  38. Ophir G, Amariglio N, Jacob-Hirsch J, Elkon R, Rechavi G, Michaelson DM. Apolipoprotein E4 enhances brain inflammation by modulation of the NF-kappaB signaling cascade. Neurobiol. Dis. 2005;20(3):709–718
  39. Perry VH, Gordon S. Resident macrophages of the central nervous system: Modulation of phenotype in relation to a specialized microenvironment. In:  Goetzl E editors. Neuroimmune Networks: Physiology and Diseases. New York, NY: Alan R. Liss, Inc.; 1989;p. 119–125
  40. Ramassamy C, Krzywkowski P, Averill D, Lussier-Cacan S, Theroux L, Christen Y, et al. Impact of apoE deficiency on oxidative insults and antioxidant levels in the brain. Brain Res. Mol. Brain Res. 2001;86:76–83
  41. Roselaar S, Daugherty A. Apolipoprotein E-deficient mice have impaired innate immune responses to Listeria monocytogenes in vivo. J. Lipid Res. 1998;39:1740–1743
  42. Roses AD. Apolipoprotein E, a gene with complex biological interactions in the aging brain. Neurobiol. Dis. 1997;4:170–185
  43. Streit W, Colton CA. The Brain's immune system. Sci. Am. 1995;273:38
  44. Sullivan P, Mezour H, Quarfordt SH, Maeda N. Type III hyperlipoproteinemia and spontaneous atherosclerosis in mice resulting from gene replacement of mouse Apoe with human Apoe2. J. Clin. Invest. 1998;102:130–135
  45. Vitek M, Snell J, Chernyshev O, Colton C. Modulation of nitric oxide production in human macrophages by apolipoprotein E and amyloid beta peptide. Biophys. Biochem. Res. Commun. 1997;240:391–394
  46. Xu PT, Schmechel D, Rothrock C, Burkhart DS, Qiu HL, Popko B, et al. Human apolipoprotein E2, E3 and E4 isoform-specific transgenic mice: human like pattern of glial and neuronal immunoreactivity in central nervous system not observed in wild type mice. Neurobiol. Dis. 1996;3:229–245

PII: S0197-4580(07)00445-9

doi: 10.1016/j.neurobiolaging.2007.11.014

Neurobiology of Aging
Volume 30, Issue 9 , Pages 1350-1360 , September 2009

Article Tools

* Image Usage & Resolution